Pandemic 2020
- Thread starter Jimdamick
- Start date
- Status
Budley Doright
Well-Known Member
And it seems Canada’s
. Our beef prices have doubled in most places here. I did find a great local butcher that has kept prices lower but they are the exception.
DIY-HP-LED
Well-Known Member
It's just a small part of the price we are all gonna pay for this shit, the Americans will pay more though. If their government doesn't come through with some cash for those folks they won't be buying food, they be starving in the midst of a plague. In the next month or two 20 to 40 million people could be evicted from their homes and will hit the streets. The banking and mortgage system will collapse, unless the government bails out the banks and fucks the people once more, the banks will freeze up and the economy goes down. Run for cover then.And it seems Canada’s
DIY-HP-LED
Well-Known Member
I kinda regret not digging up the back yard and planting potatoes...And it seems Canada’s
everything at grocery is $5 or more per item a $50 run is now $80.And it seems Canada’s
i picked up a pack of uncooked potatoes with seasoning, $5- potatoes..those little potatoes maybe 8.
DIY-HP-LED
Well-Known Member
They let millions of tons of them rot in the fields, a responsible government would have figured out a way to deliver them to food banks.
Budley Doright
Well-Known Member
Ya it’s the first time I haven’t had a garden in years but the drought is keeping me busy with my other garden
Budley Doright
Well-Known Member
French fries? Sams with mushrooms that they threw away. I fucking love mushrooms
.they don't need any more ppe:
Trump administration ends 'Project Airbridge' effort to get supplies to the US | CNN Politics
The last overseas flight to expedite shipment of supplies through the Trump administration's "Project Airbridge" initiative is scheduled to arrive in Ohio on Tuesday, according to the Federal Emergency Management Agency.
hillbill
Well-Known Member
A couple of the best humans on Earth.
DIY-HP-LED
Well-Known Member
Let's talk about Trump vs the Pediatricians....
DIY-HP-LED
Well-Known Member
Let's see, the stable jenus is cutting off supplies of PPE imports when there are shortages, in the very red states that support him most, while they are being assaulted by a pandemic that was largely Trump's and the GOP's fault. Donald is not watching and ignoring the news from those places, the local people are seeing it on the local news and many hear the wail of ambulances in the distance. Think this story will make the local news in red states with overwhelmed hospitals, no PPE and inadequate testing? Think this fiasco orchestrated by Trump the republicans and local republican politicians will harm them on a local, state and the federal level this fall? Redistricting for congress is also happening next year and many states and offices are up for grabs too, if it had to happen, the timing couldn't possibly be better for the democrats. The deaths are just starting in these states and when hospitals are overwhelmed the mortality rate goes up dramatically.they don't need any more ppe:
Trump administration ends 'Project Airbridge' effort to get supplies to the US | CNN Politics
The last overseas flight to expedite shipment of supplies through the Trump administration's "Project Airbridge" initiative is scheduled to arrive in Ohio on Tuesday, according to the Federal Emergency Management Agency.www.cnn.com
sadly we weren't ready for them.
captainmorgan
Well-Known Member
Couldn't happen to a nicer guy.
democracyinn.wordpress.com
Commissioner who Voted Against Masks in Critical Condition with COVID-19
BY @DemocracyInn St. Johns County Commissioner Paul Waldron caught the coronavirus and went into septic shock after voting against a motion to mandate masks for county employees last week. His daug…
democracyinn.wordpress.com
Budzbuddha
Well-Known Member
Hell just froze over .....
Walter Reed Medical Center.
Walter Reed Medical Center.
hanimmal
Well-Known Member
I want to make fun of him, but shit it is like watching a fragile vase teetering on a edge, any move and you are afraid it might fuck it up and he takes it off.
Budley Doright
Well-Known Member
What link? There’s nothing in the ad that talks about them zigzagging or wanting to attach to something...did I miss that? If I did I apologize and I also apologize if your feels were hurt for answering Fog and not you...how rude of me.
DIY-HP-LED
Well-Known Member
Here is an interesting story and something that could help, if there is reluctance in the USA, what about Canada or Europe? We need every tool in the arsenal and these scientist make some good points about preparation, should studies on convalescent plasma show promise. The USA will not even begin to address the raging epidemic until Trump is gone, then they can begin the hard road back.
---------------------------------------------------------------------------------------------------------------------------------------------
news.yahoo.com
A plasma shot could prevent coronavirus. But feds and makers won't act, scientists say
It might be the next best thing to a coronavirus vaccine.
Scientists have devised a way to use the antibody-rich blood plasma of COVID-19 survivors for an upper-arm injection that they say could inoculate people against the virus for months.
Using technology that’s been proven effective in preventing other diseases such as hepatitis A, the injections would be administered to high-risk healthcare workers, nursing home patients, or even at public drive-through sites — potentially protecting millions of lives, the doctors and other experts say.
The two scientists who spearheaded the proposal — an 83-year-old shingles researcher and his counterpart, an HIV gene therapy expert — have garnered widespread support from leading blood and immunology specialists, including those at the center of the nation’s COVID-19 plasma research.
But the idea exists only on paper. Federal officials have twice rejected requests to discuss the proposal, and pharmaceutical companies — even acknowledging the likely efficacy of the plan — have declined to design or manufacture the shots, according to a Times investigation. The lack of interest in launching development of immunity shots comes amid heightened scrutiny of the federal government’s sluggish pandemic response.
There is little disagreement that the idea holds promise; the dispute is over the timing. Federal health officials and industry groups say the development of plasma-based therapies should focus on treating people who are already sick, not on preventing infections in those who are still healthy.
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, said an upper-arm injection that would function like a vaccine “is a very attractive concept.”
However, he said, scientists should first demonstrate that the coronavirus antibodies that are currently delivered to patients intravenously in hospital wards across the country actually work. “Once you show the efficacy, then the obvious next step is to convert it into an intramuscular” shot.
But scientists who question the delay argue that the immunity shots are easy to scale up and should enter clinical trials immediately. They say that until there’s a vaccine, the shots offer the only plausible method for preventing potentially millions of infections at a critical moment in the pandemic.
“Beyond being a lost opportunity, this is a real head-scratcher,” said Dr. Michael Joyner, a Mayo Clinic researcher who leads a program sponsored by the Food and Drug Administration to capitalize on coronavirus antibodies from COVID-19 survivors. “It seems obvious.”
The use of so-called convalescent plasma has already become widespread. More than 28,000 patients have already received the IV treatment, and preliminary data suggest that the method is safe. Researchers are also looking at whether the IV drip products would prevent new infections from taking root.
The antibodies in plasma can be concentrated and delivered to patients through a type of drug called immune globulin, or IG, which can be given through either an IV drip or a shot. IG shots have for decades been used to prevent an array of diseases; the IG shot that prevents hepatitis A was first licensed in 1944. They are available to treat patients who have recently been exposed to hepatitis B, tetanus, varicella and rabies.
Yet for the coronavirus, manufacturers are only developing an intravenous solution of IG
more...
---------------------------------------------------------------------------------------------------------------------------------------------
A plasma shot could prevent coronavirus. But feds and makers won't act, scientists say
Scientists have devised a way to use the plasma of COVID-19 survivors for an upper arm injection that could inoculate people against the virus.
A plasma shot could prevent coronavirus. But feds and makers won't act, scientists say
It might be the next best thing to a coronavirus vaccine.
Scientists have devised a way to use the antibody-rich blood plasma of COVID-19 survivors for an upper-arm injection that they say could inoculate people against the virus for months.
Using technology that’s been proven effective in preventing other diseases such as hepatitis A, the injections would be administered to high-risk healthcare workers, nursing home patients, or even at public drive-through sites — potentially protecting millions of lives, the doctors and other experts say.
The two scientists who spearheaded the proposal — an 83-year-old shingles researcher and his counterpart, an HIV gene therapy expert — have garnered widespread support from leading blood and immunology specialists, including those at the center of the nation’s COVID-19 plasma research.
But the idea exists only on paper. Federal officials have twice rejected requests to discuss the proposal, and pharmaceutical companies — even acknowledging the likely efficacy of the plan — have declined to design or manufacture the shots, according to a Times investigation. The lack of interest in launching development of immunity shots comes amid heightened scrutiny of the federal government’s sluggish pandemic response.
There is little disagreement that the idea holds promise; the dispute is over the timing. Federal health officials and industry groups say the development of plasma-based therapies should focus on treating people who are already sick, not on preventing infections in those who are still healthy.
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, said an upper-arm injection that would function like a vaccine “is a very attractive concept.”
However, he said, scientists should first demonstrate that the coronavirus antibodies that are currently delivered to patients intravenously in hospital wards across the country actually work. “Once you show the efficacy, then the obvious next step is to convert it into an intramuscular” shot.
But scientists who question the delay argue that the immunity shots are easy to scale up and should enter clinical trials immediately. They say that until there’s a vaccine, the shots offer the only plausible method for preventing potentially millions of infections at a critical moment in the pandemic.
“Beyond being a lost opportunity, this is a real head-scratcher,” said Dr. Michael Joyner, a Mayo Clinic researcher who leads a program sponsored by the Food and Drug Administration to capitalize on coronavirus antibodies from COVID-19 survivors. “It seems obvious.”
The use of so-called convalescent plasma has already become widespread. More than 28,000 patients have already received the IV treatment, and preliminary data suggest that the method is safe. Researchers are also looking at whether the IV drip products would prevent new infections from taking root.
The antibodies in plasma can be concentrated and delivered to patients through a type of drug called immune globulin, or IG, which can be given through either an IV drip or a shot. IG shots have for decades been used to prevent an array of diseases; the IG shot that prevents hepatitis A was first licensed in 1944. They are available to treat patients who have recently been exposed to hepatitis B, tetanus, varicella and rabies.
Yet for the coronavirus, manufacturers are only developing an intravenous solution of IG
more...
- Status